despit
success
vaccin
chemoprevent
chemotherapi
human
respiratori
viral
infect
diseas
still
one
lead
caus
human
infecti
disord
adenovirus
caus
keratoconjunct
well
respiratori
urogenit
intestin
tract
infecti
diseas
addit
adenovirus
may
persist
lymphoid
tissu
tonsil
adenoid
long
time
caus
upper
respiratori
tract
infect
adult
variou
compound
found
effect
adenovirus
antiadenovir
activ
shown
vitro
nucleotid
analog
ribavirin
affect
mani
dna
rnacontain
virus
found
effect
partial
effect
effect
adenovir
infect
ganciclovir
effici
cytomegaloviru
infect
effect
adenovirus
vitro
vivo
cidofovir
character
broad
spectrum
antivir
activ
use
treatment
sever
adenovir
infect
ribavirin
ganciclovir
cidofovir
less
success
use
treatment
sever
human
adenovir
patholog
includ
hepat
cystiti
pneumonia
immunocompromis
organ
transplant
recipi
time
appar
advers
effect
abil
adenovirus
form
resist
strain
limit
use
drug
chemic
distinct
compound
includ
lipid
acridon
imidazoquinolinamin
well
analog
nucleosid
also
show
antiadenovir
activ
viru
reproduct
cell
cultur
may
inhibit
high
concentr
green
tea
catechin
interferon
drug
use
treat
respiratori
infect
use
prevent
consid
primari
medic
treatment
sever
infect
adenovirus
effect
mechan
suppress
interferoninduc
antivir
cascad
resist
action
interferon
induc
therefor
develop
new
antivir
drug
would
effect
adenovirus
without
advers
effect
wide
rang
patient
includ
longterm
user
urgent
current
use
probiot
antagonist
microorgan
metabol
product
repres
promis
approach
treatment
viral
diseas
lactic
acid
bacteria
lab
found
microbiota
mucou
membran
nose
mouth
gastrointestin
urinari
tract
posit
effect
ecosystem
stimul
immun
system
increas
resist
infect
bacteri
viral
origin
lab
sourc
multipl
biolog
activ
substanc
vari
chemic
structur
action
spectrum
metabol
process
lactic
acid
bacteria
produc
vital
substanc
includ
vitamin
amino
acid
enzym
fatti
acid
exopolysaccharid
lactic
acid
bacteriocin
hydrogen
peroxid
significantli
improv
intestin
absorpt
micro
macroel
essenti
organ
also
shown
exopolysaccharid
secret
cultiv
lab
addit
probiot
activ
act
select
pathogen
microb
virus
without
signific
disturb
microbiocenosi
develop
inflammatori
process
occur
use
broadspectrum
antibiot
chemic
antivir
agent
result
exopolysaccharid
use
base
product
harmless
nontox
acellular
probiot
product
drug
target
therapeut
effect
present
studi
aim
investig
antivir
activ
exopolysaccharid
produc
lactic
acid
bacteria
genera
pediococcu
leuconostoc
lactobacillu
human
adenoviru
type
studi
mdbk
cell
obtain
tissu
cultur
collect
institut
virolog
bulgarian
academi
scienc
sofia
bulgaria
obtain
collect
institut
microbiolog
budapest
univers
medic
scienc
budapest
hungari
propag
atcc
cell
mdbk
cell
maintain
steril
plastic
falcon
sarstedt
ag
co
kg
germani
growth
medium
compos
dmem
sigmaaldrich
st
loui
mo
usa
rpmi
sigmaaldrich
st
loui
mo
usa
fetal
bovin
serum
fb
sigmaaldrich
st
loui
mo
usa
heat
inactiv
antibiot
penicillin
sigmaaldrich
st
loui
mo
usa
streptomycin
sigmaaldrich
st
loui
mo
usa
cultiv
purif
preserv
perform
accord
standard
method
infecti
titer
viru
mdbk
cell
cultur
pfuml
exopolysaccharid
epss
produc
lactic
acid
bacteria
genera
pediococcu
leuconostoc
lactobacillu
extract
purifi
accumul
research
depart
physiolog
industri
microorgan
zabolotni
institut
microbiolog
virolog
nation
academi
scienc
ukrain
tabl
ribavirin
rib
sigmaaldrich
st
loui
mo
usa
use
refer
compound
mttassay
use
analysi
cell
viabil
h
growth
growth
medium
monolay
mdbk
cell
plate
incub
ep
concentr
control
cell
incub
fresh
medium
lack
ep
h
total
mtt
solut
tetrazolium
bromid
sigmaaldrich
st
loui
mo
usa
ad
well
cell
incub
h
medium
remov
ethanol
ad
plate
read
use
multiskan
fc
thermo
scientif
waltham
usa
test
wavelength
percentag
decreas
cell
viabil
condit
ep
action
calcul
follow
formula
decreas
cell
viabil
ab
mean
optic
densiti
studi
sampl
certain
concentr
b
mean
optic
densiti
control
cell
sampl
ep
concentr
cell
viabil
inhibit
estim
comparison
control
cell
treat
ep
mdbk
cell
infect
adenoviru
treat
treat
epss
fix
icecold
ethanol
h
resuspend
ml
solut
phosphatebuff
salin
sigmaaldrich
st
loui
mo
usa
contain
rnase
applichem
gmbh
darmstadt
germani
propidium
iodid
pi
sigmaaldrich
st
loui
mo
usa
incub
room
temper
dark
place
h
cell
fluoresc
intens
measur
flow
cytomet
beckman
coulter
epic
lx
minneapoli
mn
usa
laser
wavelength
nm
total
cell
sort
per
sampl
cell
cycl
profil
analyz
program
flow
softwar
v
cell
imag
core
finland
mdbk
cell
ad
epss
concentr
incub
h
cell
infect
multipl
infect
moi
pfu
per
cell
h
viruscontain
medium
remov
serumfre
medium
ad
adenoviru
moi
pfucel
mix
equal
volum
ep
concentr
incub
h
mdbk
cell
monolay
infect
per
well
suspens
appropri
dilut
follow
viru
adsorpt
carri
h
viruscontain
materi
remov
serumfre
medium
ad
mdbk
cell
first
infect
moi
pfucel
viru
adsorb
h
viru
remov
growth
medium
appropri
epss
concentr
ad
plate
cell
kept
visibl
cytopath
effect
adenoviru
appear
day
viru
materi
select
investig
viru
titer
nontreat
cell
cell
treat
serv
control
titer
viru
determin
plaqu
method
base
format
necrot
site
infect
cell
due
reproduct
viru
cell
grown
plate
tpp
trasadingen
switzerland
form
monolay
infect
serial
tenfold
dilut
lysat
cell
previous
infect
adenoviru
untreat
treat
differ
concentr
epss
ml
per
well
incub
h
adsorpt
viru
medium
remov
cell
cover
methylcellulos
sigmaaldrich
st
loui
mo
usa
dmem
medium
sigmaaldrich
st
loui
mo
usa
fetal
bovin
serum
sigmaaldrich
st
loui
mo
usa
cell
incub
day
next
cover
remov
crystal
violet
sigmaaldrich
st
loui
mo
usa
ethanol
ad
cell
monolay
titer
viru
determin
highest
dilut
viru
virusinduc
plaqu
form
accord
formula
viru
titer
pfuml
b
c
number
plaqu
b
dilut
viru
c
volum
inoculum
antivir
activ
epss
determin
use
follow
formula
inhibit
viru
titer
experi
viru
titer
control
decreas
infecti
titer
viru
lg
compar
control
indic
signific
activ
compound
viru
demonstr
moder
effect
less
show
rel
activ
statist
data
process
perform
accord
standard
approach
calcul
statist
error
standard
deviat
use
microsoft
excel
result
express
mean
sd
three
independ
experi
student
ttest
unpair
twosid
ttest
use
evalu
differ
test
sampl
control
p
valu
consid
statist
signific
issu
direct
inhibit
reproduct
infecti
diseas
pathogen
requir
search
medicin
character
low
toxic
broad
spectrum
antivir
activ
virus
intracellular
parasit
select
suppress
viru
reproduct
without
advers
effect
viabil
host
cell
one
requir
antivir
inhibitor
mtt
analysi
one
simpl
avail
method
estim
cytotox
techniqu
enabl
identif
neg
impact
epss
viabil
cell
function
activ
mitochondria
figur
found
epss
concentr
toxic
mdbk
cell
suppress
viabil
wherea
valu
significantli
higher
valu
refer
compound
ribavirin
toxic
compound
often
caus
termin
cell
growth
prolifer
effect
epss
mdbk
cell
popul
studi
cell
fix
dy
fluorochrom
propidium
iodid
analyz
use
flow
cytometri
approach
allow
estim
distribut
cell
structur
cell
cycl
phase
well
identif
apoptot
cell
propidium
iodid
signal
directli
proport
dna
content
seen
cell
cycl
profil
figur
base
distribut
cell
accord
structur
cell
cycl
phase
histogram
epstreat
control
mdbk
cell
similar
ident
reveal
h
growth
control
mdbk
cell
remain
phase
phase
phase
figur
condit
compound
treatment
distribut
cell
phase
similar
control
cell
howev
compar
control
cell
epss
decreas
number
cell
phase
wherea
epss
increas
number
cell
phase
activ
epss
nontox
concentr
confirm
measur
viru
yield
synthes
de
novo
use
plaqu
reduct
assay
analysi
antivir
activ
epss
ad
mdbk
cell
h
adenoviru
infect
demonstr
epss
show
low
antivir
activ
reduc
viru
reproduct
figur
indic
ineffici
ep
use
accord
suggest
treatment
approach
found
ep
show
weak
virucid
activ
decreas
infecti
titer
wherea
incub
viru
ep
increas
reproduct
figur
use
epss
late
stage
adenoviru
reproduct
immedi
viru
adsorpt
found
ep
show
appar
activ
concentr
ep
absolut
block
synthesi
viral
progeni
figur
epss
use
analyz
concentr
reduc
infecti
titer
viru
use
ribavirin
concentr
infect
cell
adenoviru
result
decreas
reproduct
data
shown
viru
infect
frequent
result
disturb
key
cellular
process
within
host
cell
subvers
cell
cycl
pathway
wellestablish
mechan
virus
creat
suitabl
environ
replic
notabl
induct
sphase
either
mandatori
least
advantag
lytic
replic
number
virus
adenovir
infect
report
effect
cell
cycl
wellknown
adenovir
gene
product
interact
prb
retinoblastoma
protein
caus
releas
transcript
factor
potenti
transit
phase
product
greatest
hadv
infect
rang
epitheli
cell
line
includ
primari
cell
line
caus
phase
synchron
cell
cycl
arrest
synchron
phase
may
signific
factor
contribut
cellsiz
increas
therefor
influenc
epss
cell
cycl
condit
adenoviru
infect
analyz
use
flow
cytometr
analysi
signific
chang
cell
cycl
cell
infect
compar
noninfect
cell
reveal
particular
number
cell
phase
decreas
wherea
number
cell
phase
doubl
figur
reduct
cell
popul
phase
demonstr
suppress
transit
cell
mitot
phase
infect
cell
enter
phase
phase
block
cell
produc
viral
dna
late
viral
protein
virion
cell
destroy
detach
monolay
found
treatment
cell
infect
adenoviru
use
exopolysaccharid
distribut
cell
cell
cycl
phase
similar
distribut
cell
infect
adenoviru
demonstr
ineffici
exopolysaccharid
treatment
data
shown
decreas
number
cell
phase
compar
distribut
infect
cell
observ
howev
increas
number
cell
phase
indic
continu
block
mitot
phase
cell
cycl
due
viral
infect
use
ep
concentr
result
signific
increas
number
cell
phase
time
compar
infect
cell
decreas
number
cell
synthet
phase
indic
normal
cell
cycl
infect
cell
level
uninfect
cell
figur
recent
year
tendenc
use
lab
exopolysaccharid
treatment
infect
respiratori
tract
gastrointestin
tract
urinari
system
well
cancer
allerg
diseas
viral
infect
howev
despit
wide
rang
applic
lactic
acid
bacteria
exopolysaccharid
role
live
organ
biolog
activ
fulli
understood
product
exopolysaccharid
ep
lactic
acid
bacteria
lab
intens
studi
signific
amount
data
describ
composit
structur
properti
accumul
ep
produc
strain
found
among
repres
genera
streptococcu
lactococcu
lactobacillu
leuconostoc
pediococcu
weissella
lab
exopolysaccharid
uniqu
physic
rheolog
properti
result
use
food
industri
bind
stabil
gelform
agent
specif
product
dairi
product
recent
year
much
attent
paid
studi
biolog
activ
epss
particular
shown
immunostimul
antitumor
antioxid
qualiti
sinc
biolog
activ
epss
strainspecif
search
new
strainproduc
among
lab
repres
found
natur
microbiota
ferment
product
great
interest
strain
produc
epss
especi
high
amount
import
improv
rheolog
properti
product
may
possess
possibl
healthimprov
effect
human
bodi
previous
search
lab
strain
produc
exopolysaccharid
perform
isol
lab
present
tradit
ferment
milk
product
ferment
fruit
veget
analyz
ep
produc
found
among
repres
genera
lactobacillu
leuconostoc
pediococcu
isol
pickl
appl
pickl
tomato
juic
sauerkraut
therefor
biolog
activ
epss
analyz
current
work
preclin
studi
potenti
drug
first
step
associ
assess
compound
toxic
cell
cultur
name
studi
effect
differ
concentr
structur
function
properti
cell
note
toxic
agent
act
cell
interf
molecular
mechan
homeostasi
action
express
whole
set
effect
includ
chang
fundament
cellular
reaction
lead
destruct
effect
studi
impact
epss
extract
lactic
acid
bacteria
genera
pediococcu
leuconostoc
lactobacillu
growth
divis
mdbk
cell
sensit
adenoviru
identifi
epss
studi
concentr
toxic
mdbk
cell
sinc
reduc
cell
viabil
also
analysi
effect
highest
ep
concentr
cell
cycl
mdbk
cell
show
absenc
signific
chang
distribut
cell
popul
phase
cycl
obtain
data
allow
use
epss
studi
antivir
potenti
known
bacteri
exopolysaccharid
show
signific
antivir
activ
due
degrad
viral
particl
decreas
titer
virus
block
viral
dna
replic
releas
infecti
viru
particl
howev
antivir
potenti
drug
studi
suffici
result
investig
exhibit
epsmedi
antiadenovir
activ
determin
stage
viral
reproduct
inhibit
ep
variou
ep
treatment
scheme
use
work
base
three
differ
treatment
result
suggest
epss
specif
inhibitori
effect
epss
show
low
virucid
activ
reduc
infect
case
neither
pretreat
result
signific
inactiv
virion
infect
inhibitori
effect
observ
epss
ad
cell
end
viru
adsorpt
period
howev
ep
produc
lactobacillu
sp
reduc
titer
viru
obtain
de
novo
inhibit
plaqu
format
current
sever
possibl
mechan
influenc
lactic
acid
bacteria
metabolit
develop
viral
infect
identifi
inhibit
viru
adsorpt
penetr
cell
result
direct
bacteriummetaboliteviru
interact
ii
inhibit
late
stage
viral
reproduct
reduct
infect
iii
stimul
immun
system
result
shown
probiot
captur
viru
vesicular
stomat
vsv
direct
interact
lab
cell
l
paracasei
l
paracasei
l
paracaseirhamnosu
l
plantarum
l
reuteri
lipid
envelop
vsv
lead
block
viru
adsorpt
cell
similar
data
shown
e
faecium
ncimb
influenza
virus
l
gasseri
isol
vagin
microbiota
herp
simplex
viru
type
probiot
lactic
acid
bacteria
lactobacillu
exopolysaccharid
stimul
synthesi
accumul
interleukin
enhanc
activ
natur
killer
cell
synthesi
iga
spleen
activ
immun
respons
product
iga
determin
action
influenza
addit
direct
interact
virus
lab
bacteria
synthes
metabolit
antivir
activ
result
hydrogen
peroxid
produc
lactobacillu
sp
play
essenti
role
natur
microbocid
within
vagin
ecosystem
toxic
human
immunodefici
viru
type
lactic
acid
final
product
carbohydr
metabol
synthes
type
lactobacilli
essenti
maintain
requir
ph
genit
organ
sinc
known
acid
ph
environ
inactiv
hiv
reveal
lactobacilli
produc
compound
inhibit
replic
virus
l
brevi
cell
wall
inhibit
replic
dna
cell
cultur
acid
product
lactobacillu
metabol
inhibit
activ
tlymphocyt
lead
decreas
sensit
lymphocyt
hiv
infect
especi
import
mix
infect
establish
type
bacteriocin
exopolysaccharid
appar
virucid
effect
influenza
hiv
newcastl
diseas
characterist
chang
dna
synthesi
content
induc
infect
allow
use
flow
cytometri
detect
viral
infect
also
potenti
antivir
activ
influenc
epss
cell
cycl
condit
adenoviru
infect
studi
use
flow
cytometr
analysi
propidium
iodidestain
cell
use
epss
lead
normal
life
cycl
infect
cell
level
noninfect
cell
number
cell
phase
decreas
significantli
except
ep
transit
cell
phase
indic
block
mitosi
infect
cell
taken
togeth
data
suggest
exopolysaccharid
produc
lab
strain
exhibit
activ
vitro
among
six
use
strain
one
lab
strain
lactobacillu
sp
produc
ep
suppress
yield
viru
particl
select
furthermor
strain
interest
potenti
probiot
starter
wherea
indepth
investig
function
technolog
properti
epss
monosaccharid
composit
structur
current
studi
summari
ep
produc
lactobacillu
sp
possess
signific
activ
base
obstruct
reproduct
induc
format
noninfecti
viru
progeni
thu
lab
strain
promis
produc
ep
antivir
activ
howev
investig
need
explor
antivir
mechan
ep
detail
